

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | serine family amino acid catabolic process (GO:0009071) | 5.17869775 |
| 2 | glycine metabolic process (GO:0006544) | 4.69488665 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.60880373 |
| 4 | regulation of cholesterol homeostasis (GO:2000188) | 4.07331440 |
| 5 | pre-miRNA processing (GO:0031054) | 3.87414679 |
| 6 | cysteine metabolic process (GO:0006534) | 3.78416386 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.76914450 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 3.76914450 |
| 9 | serine family amino acid metabolic process (GO:0009069) | 3.75595412 |
| 10 | kynurenine metabolic process (GO:0070189) | 3.71428921 |
| 11 | lysine metabolic process (GO:0006553) | 3.70734030 |
| 12 | lysine catabolic process (GO:0006554) | 3.70734030 |
| 13 | folic acid metabolic process (GO:0046655) | 3.70644495 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 3.70638072 |
| 15 | mannose metabolic process (GO:0006013) | 3.69155791 |
| 16 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.68655405 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.63838720 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 3.63838720 |
| 19 | carnitine shuttle (GO:0006853) | 3.63527315 |
| 20 | 2-oxoglutarate metabolic process (GO:0006103) | 3.54250488 |
| 21 | regulation of ARF GTPase activity (GO:0032312) | 3.53292231 |
| 22 | anterior/posterior axis specification, embryo (GO:0008595) | 3.52862799 |
| 23 | amino-acid betaine metabolic process (GO:0006577) | 3.51845649 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 3.46389484 |
| 25 | regulation of ARF protein signal transduction (GO:0032012) | 3.43862469 |
| 26 | glyoxylate metabolic process (GO:0046487) | 3.35345713 |
| 27 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.31102785 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 3.28254726 |
| 29 | homocysteine metabolic process (GO:0050667) | 3.26347773 |
| 30 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.24174393 |
| 31 | biotin metabolic process (GO:0006768) | 3.23270428 |
| 32 | regulation of hippo signaling (GO:0035330) | 3.20746762 |
| 33 | paraxial mesoderm development (GO:0048339) | 3.16251534 |
| 34 | adherens junction assembly (GO:0034333) | 3.13632003 |
| 35 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.12491098 |
| 36 | negative regulation of cell killing (GO:0031342) | 3.11924716 |
| 37 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11924716 |
| 38 | cell-cell junction maintenance (GO:0045217) | 3.11477563 |
| 39 | intestinal epithelial cell development (GO:0060576) | 3.11059629 |
| 40 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.10828921 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.10699956 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.10699956 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.10699956 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.10699956 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.10699956 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.10699956 |
| 47 | urea cycle (GO:0000050) | 3.10131707 |
| 48 | urea metabolic process (GO:0019627) | 3.10131707 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.08835903 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.08835903 |
| 51 | tryptophan catabolic process (GO:0006569) | 3.08835903 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 3.08543286 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 3.08110456 |
| 54 | regulation of translational termination (GO:0006449) | 3.07813994 |
| 55 | focal adhesion assembly (GO:0048041) | 3.06501170 |
| 56 | cell-substrate adherens junction assembly (GO:0007045) | 3.06501170 |
| 57 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.02657334 |
| 58 | alpha-linolenic acid metabolic process (GO:0036109) | 3.00979382 |
| 59 | regulation of protein activation cascade (GO:2000257) | 2.99220526 |
| 60 | detection of bacterium (GO:0016045) | 2.97980213 |
| 61 | signal complex assembly (GO:0007172) | 2.96987281 |
| 62 | apoptotic process involved in morphogenesis (GO:0060561) | 2.96753380 |
| 63 | detection of other organism (GO:0098543) | 2.96685329 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 2.94829481 |
| 65 | semaphorin-plexin signaling pathway (GO:0071526) | 2.94728479 |
| 66 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.94182985 |
| 67 | fatty acid homeostasis (GO:0055089) | 2.93546701 |
| 68 | response to muramyl dipeptide (GO:0032495) | 2.93459460 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 2.91016741 |
| 70 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.90524387 |
| 71 | maternal placenta development (GO:0001893) | 2.90210138 |
| 72 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.89639973 |
| 73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.87862258 |
| 74 | tryptophan metabolic process (GO:0006568) | 2.87166867 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.86905224 |
| 76 | response to laminar fluid shear stress (GO:0034616) | 2.85276971 |
| 77 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.83548180 |
| 78 | histone H3-K36 demethylation (GO:0070544) | 2.82483266 |
| 79 | heme transport (GO:0015886) | 2.80912173 |
| 80 | regulation of complement activation (GO:0030449) | 2.80245503 |
| 81 | fructose metabolic process (GO:0006000) | 2.79754473 |
| 82 | NADH metabolic process (GO:0006734) | 2.79531897 |
| 83 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.78618616 |
| 84 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.78132970 |
| 85 | regulation of bile acid biosynthetic process (GO:0070857) | 2.77875799 |
| 86 | vitamin transmembrane transport (GO:0035461) | 2.77669267 |
| 87 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.77298959 |
| 88 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.76505597 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 2.76401203 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 2.76349029 |
| 91 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.76237275 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.76023214 |
| 93 | protein carboxylation (GO:0018214) | 2.76023214 |
| 94 | purine nucleobase biosynthetic process (GO:0009113) | 2.75720343 |
| 95 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.75124499 |
| 96 | glutamate metabolic process (GO:0006536) | 2.74134706 |
| 97 | trophectodermal cell differentiation (GO:0001829) | 2.74104649 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 2.73641019 |
| 99 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73104491 |
| 100 | negative regulation of cell size (GO:0045792) | 2.72764774 |
| 101 | nitrogen cycle metabolic process (GO:0071941) | 2.72432454 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.71973827 |
| 103 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.71062179 |
| 104 | regulation of gene silencing by miRNA (GO:0060964) | 2.71062179 |
| 105 | regulation of gene silencing by RNA (GO:0060966) | 2.71062179 |
| 106 | leukocyte aggregation (GO:0070486) | 2.70836199 |
| 107 | response to peptidoglycan (GO:0032494) | 2.69879101 |
| 108 | mitotic G1/S transition checkpoint (GO:0044819) | 2.69510647 |
| 109 | regulation of fibrinolysis (GO:0051917) | 2.69023359 |
| 110 | positive regulation of histone deacetylation (GO:0031065) | 2.68684178 |
| 111 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.67803520 |
| 112 | embryonic placenta development (GO:0001892) | 2.67732792 |
| 113 | acylglycerol homeostasis (GO:0055090) | 2.66590342 |
| 114 | triglyceride homeostasis (GO:0070328) | 2.66590342 |
| 115 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.66490912 |
| 116 | atrioventricular valve morphogenesis (GO:0003181) | 2.66315426 |
| 117 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.65942984 |
| 118 | protein localization to endosome (GO:0036010) | 2.65550858 |
| 119 | regulation of RNA export from nucleus (GO:0046831) | 2.65092464 |
| 120 | negative regulation of histone methylation (GO:0031061) | 2.64934205 |
| 121 | positive regulation of receptor recycling (GO:0001921) | 2.63599801 |
| 122 | labyrinthine layer development (GO:0060711) | 2.62595802 |
| 123 | bile acid biosynthetic process (GO:0006699) | 2.62558607 |
| 124 | negative regulation of glial cell proliferation (GO:0060253) | 2.62503411 |
| 125 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.62121030 |
| 126 | complement activation, alternative pathway (GO:0006957) | 2.61951748 |
| 127 | protein targeting to plasma membrane (GO:0072661) | 2.61880014 |
| 128 | heterochromatin organization (GO:0070828) | 2.60664355 |
| 129 | activation of Rac GTPase activity (GO:0032863) | 2.59915523 |
| 130 | aromatic amino acid family metabolic process (GO:0009072) | 2.58819662 |
| 131 | nucleobase biosynthetic process (GO:0046112) | 2.58675397 |
| 132 | histone H2A monoubiquitination (GO:0035518) | 2.58506123 |
| 133 | embryonic process involved in female pregnancy (GO:0060136) | 2.58308468 |
| 134 | histone H3-K9 demethylation (GO:0033169) | 2.57912160 |
| 135 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.57610183 |
| 136 | G1 DNA damage checkpoint (GO:0044783) | 2.57133959 |
| 137 | carnitine metabolic process (GO:0009437) | 2.56939356 |
| 138 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.56418947 |
| 139 | positive regulation of Rap GTPase activity (GO:0032854) | 2.55957939 |
| 140 | negative regulation of sterol transport (GO:0032372) | 2.55740138 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 2.55740138 |
| 142 | histone H4-K12 acetylation (GO:0043983) | 2.55705956 |
| 143 | stress fiber assembly (GO:0043149) | 2.55396561 |
| 144 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.54469553 |
| 145 | detection of external biotic stimulus (GO:0098581) | 2.54336726 |
| 146 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.54263705 |
| 147 | bile acid metabolic process (GO:0008206) | 2.54031031 |
| 148 | histone H4-K5 acetylation (GO:0043981) | 2.53442696 |
| 149 | histone H4-K8 acetylation (GO:0043982) | 2.53442696 |
| 150 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.53387621 |
| 151 | determination of adult lifespan (GO:0008340) | 2.52904962 |
| 152 | negative regulation of fatty acid transport (GO:2000192) | 2.52401121 |
| 153 | carnitine transmembrane transport (GO:1902603) | 2.52294175 |
| 154 | nuclear pore organization (GO:0006999) | 2.52283221 |
| 155 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.51695315 |
| 156 | regulation of regulated secretory pathway (GO:1903305) | 2.50051226 |
| 157 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.49051934 |
| 158 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48026797 |
| 159 | modulation by virus of host process (GO:0019054) | 2.44535470 |
| 160 | activation of JUN kinase activity (GO:0007257) | 2.42812331 |
| 161 | regulation of chromatin binding (GO:0035561) | 2.42320722 |
| 162 | regulation of leukocyte degranulation (GO:0043300) | 2.42144932 |
| 163 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.41256083 |
| 164 | histone lysine demethylation (GO:0070076) | 2.40958383 |
| 165 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.40594078 |
| 166 | thymic T cell selection (GO:0045061) | 2.39622219 |
| 167 | macrophage activation involved in immune response (GO:0002281) | 2.38800961 |
| 168 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.38418072 |
| 169 | regulation of histone H3-K27 methylation (GO:0061085) | 2.38246740 |
| 170 | modulation by symbiont of host cellular process (GO:0044068) | 2.37582335 |
| 171 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.37229767 |
| 172 | histone H4 deacetylation (GO:0070933) | 2.35714274 |
| 173 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.34444903 |
| 174 | cell junction maintenance (GO:0034331) | 2.33566791 |
| 175 | cell-substrate junction assembly (GO:0007044) | 2.33214341 |
| 176 | detection of molecule of bacterial origin (GO:0032490) | 2.31827376 |
| 177 | negative regulation of myotube differentiation (GO:0010832) | 2.31521063 |
| 178 | glucose 6-phosphate metabolic process (GO:0051156) | 2.31245053 |
| 179 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.30550019 |
| 180 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.30129330 |
| 181 | regulation of lipid kinase activity (GO:0043550) | 2.28765265 |
| 182 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.28258467 |
| 183 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.27690186 |
| 184 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.27172233 |
| 185 | histone demethylation (GO:0016577) | 2.26508807 |
| 186 | positive regulation of protein dephosphorylation (GO:0035307) | 2.26352368 |
| 187 | positive regulation of synapse maturation (GO:0090129) | 2.25764056 |
| 188 | detection of biotic stimulus (GO:0009595) | 2.24644471 |
| 189 | cellular response to virus (GO:0098586) | 2.24218674 |
| 190 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.23983129 |
| 191 | germinal center formation (GO:0002467) | 2.23152975 |
| 192 | modulation by virus of host morphology or physiology (GO:0019048) | 2.23033324 |
| 193 | basement membrane organization (GO:0071711) | 2.20867284 |
| 194 | positive thymic T cell selection (GO:0045059) | 2.19002383 |
| 195 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.18971428 |
| 196 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.18728558 |
| 197 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.14612650 |
| 198 | response to host defenses (GO:0052200) | 2.14612650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.36761309 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22386376 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.10582037 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.03404170 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.87144511 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.80774721 |
| 7 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.78257386 |
| 8 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.76530128 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.71323074 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71232088 |
| 11 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.58166999 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.56403101 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.56403101 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.56403101 |
| 15 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.46689661 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.44495689 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.41918778 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36431038 |
| 19 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.33708666 |
| 20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.33237015 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.22543661 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.11499276 |
| 23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.08558873 |
| 24 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.08198932 |
| 25 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.07395859 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96122697 |
| 27 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.93958102 |
| 28 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.91828684 |
| 29 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.85465307 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.84919065 |
| 31 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.84618800 |
| 32 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.82812748 |
| 33 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.82050359 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.76202429 |
| 35 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.75424948 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73168329 |
| 37 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.70187841 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69681491 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67677991 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63832557 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63420854 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.62916197 |
| 43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62642789 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.60180269 |
| 45 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.58387063 |
| 46 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55955317 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.55770440 |
| 48 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.55582700 |
| 49 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.54596724 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53365280 |
| 51 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52975935 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49453700 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48435931 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48395309 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48080608 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.46854900 |
| 57 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45895820 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44959894 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43656039 |
| 60 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.42233228 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.40369715 |
| 62 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.40200463 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40135412 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40128050 |
| 65 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.38743000 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38206849 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37762600 |
| 68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.37285264 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36206230 |
| 70 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.36069278 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35617294 |
| 72 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35394729 |
| 73 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.34820217 |
| 74 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.34431553 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.34402830 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34264728 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34152479 |
| 78 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.33778415 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33147546 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31768623 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30277583 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30228064 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30224704 |
| 84 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.29476384 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29138516 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28754193 |
| 87 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28559231 |
| 88 | * MAF_26560356_Chip-Seq_TH2_Human | 1.28545242 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26462053 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26451262 |
| 91 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.26053527 |
| 92 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.25324521 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24478628 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24355444 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22672283 |
| 96 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.22604948 |
| 97 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.21017279 |
| 98 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.20976068 |
| 99 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.20947119 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19844703 |
| 101 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18197413 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16552218 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15528658 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15493960 |
| 105 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14977603 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14185303 |
| 107 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13558886 |
| 108 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13517547 |
| 109 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13012447 |
| 110 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12466132 |
| 111 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12425969 |
| 112 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12188405 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 1.11739357 |
| 114 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.11733150 |
| 115 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10707915 |
| 116 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10630033 |
| 117 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.09812043 |
| 118 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08453535 |
| 119 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08426169 |
| 120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08160085 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07201052 |
| 122 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.07143335 |
| 123 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07101637 |
| 124 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06887716 |
| 125 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06244565 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.05938083 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05883887 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05855353 |
| 129 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.05646924 |
| 130 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.05448903 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04362480 |
| 132 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04189502 |
| 133 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03005466 |
| 134 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02593104 |
| 135 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.02524154 |
| 136 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02471882 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01358315 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01056909 |
| 139 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00909417 |
| 140 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00646623 |
| 141 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00388432 |
| 142 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.98652809 |
| 143 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97758293 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97563564 |
| 145 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96832110 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96564131 |
| 147 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96156651 |
| 148 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95194106 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94716138 |
| 150 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94707396 |
| 151 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92958428 |
| 152 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92862183 |
| 153 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92665535 |
| 154 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.92419000 |
| 155 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90277756 |
| 156 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89046373 |
| 157 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89035464 |
| 158 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88577515 |
| 159 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.88204544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005085_abnormal_gallbladder_physiolo | 3.77399617 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.76755669 |
| 3 | MP0005365_abnormal_bile_salt | 3.66677956 |
| 4 | MP0005360_urolithiasis | 3.63386197 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.45837615 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.44050211 |
| 7 | MP0003436_decreased_susceptibility_to | 2.76280703 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.64541438 |
| 9 | MP0009840_abnormal_foam_cell | 2.63967859 |
| 10 | MP0005409_darkened_coat_color | 2.51912711 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.37917315 |
| 12 | MP0003303_peritoneal_inflammation | 2.25673135 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.23009117 |
| 14 | MP0002249_abnormal_larynx_morphology | 2.20114078 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.17996433 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.17124268 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.14166309 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.06286435 |
| 19 | MP0004381_abnormal_hair_follicle | 2.05301450 |
| 20 | MP0003646_muscle_fatigue | 1.96511786 |
| 21 | MP0005083_abnormal_biliary_tract | 1.95981276 |
| 22 | MP0004510_myositis | 1.95740886 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90151320 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.86822330 |
| 25 | MP0002269_muscular_atrophy | 1.84584781 |
| 26 | MP0001348_abnormal_lacrimal_gland | 1.82348100 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.82164281 |
| 28 | * MP0008260_abnormal_autophagy | 1.75587407 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.74284769 |
| 30 | MP0003252_abnormal_bile_duct | 1.73589944 |
| 31 | MP0003879_abnormal_hair_cell | 1.69912599 |
| 32 | MP0003878_abnormal_ear_physiology | 1.68503775 |
| 33 | MP0005377_hearing/vestibular/ear_phenot | 1.68503775 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.67984025 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.67969186 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.65369222 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.65268370 |
| 38 | MP0004130_abnormal_muscle_cell | 1.65198862 |
| 39 | MP0005332_abnormal_amino_acid | 1.63311246 |
| 40 | MP0005380_embryogenesis_phenotype | 1.61402368 |
| 41 | MP0001672_abnormal_embryogenesis/_devel | 1.61402368 |
| 42 | MP0001730_embryonic_growth_arrest | 1.59966954 |
| 43 | MP0008961_abnormal_basal_metabolism | 1.57897621 |
| 44 | MP0004947_skin_inflammation | 1.57842273 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.54610377 |
| 46 | MP0003984_embryonic_growth_retardation | 1.51799638 |
| 47 | MP0002088_abnormal_embryonic_growth/wei | 1.51720685 |
| 48 | MP0000609_abnormal_liver_physiology | 1.50579836 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.50293837 |
| 50 | MP0005670_abnormal_white_adipose | 1.49562184 |
| 51 | MP0001849_ear_inflammation | 1.48386028 |
| 52 | MP0000751_myopathy | 1.45862938 |
| 53 | MP0004233_abnormal_muscle_weight | 1.44822852 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.44374293 |
| 55 | MP0001958_emphysema | 1.44324080 |
| 56 | MP0003329_amyloid_beta_deposits | 1.41473155 |
| 57 | MP0002086_abnormal_extraembryonic_tissu | 1.41250403 |
| 58 | MP0005330_cardiomyopathy | 1.40749006 |
| 59 | MP0003077_abnormal_cell_cycle | 1.40727174 |
| 60 | MP0003119_abnormal_digestive_system | 1.40681211 |
| 61 | MP0000750_abnormal_muscle_regeneration | 1.40393807 |
| 62 | MP0003567_abnormal_fetal_cardiomyocyte | 1.39388961 |
| 63 | MP0009278_abnormal_bone_marrow | 1.38183803 |
| 64 | MP0002084_abnormal_developmental_patter | 1.36912621 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.31656911 |
| 66 | MP0009672_abnormal_birth_weight | 1.30379543 |
| 67 | MP0004087_abnormal_muscle_fiber | 1.29587527 |
| 68 | MP0003724_increased_susceptibility_to | 1.27184665 |
| 69 | MP0004197_abnormal_fetal_growth/weight/ | 1.26972389 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 1.26964476 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.26734406 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 1.26488738 |
| 73 | MP0003279_aneurysm | 1.25122159 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.24694185 |
| 75 | MP0010630_abnormal_cardiac_muscle | 1.23803089 |
| 76 | MP0004264_abnormal_extraembryonic_tissu | 1.21699196 |
| 77 | MP0008057_abnormal_DNA_replication | 1.21154999 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 1.20694988 |
| 79 | MP0000350_abnormal_cell_proliferation | 1.20232650 |
| 80 | MP0002085_abnormal_embryonic_tissue | 1.20179076 |
| 81 | MP0003828_pulmonary_edema | 1.19064122 |
| 82 | MP0000747_muscle_weakness | 1.17949444 |
| 83 | MP0001697_abnormal_embryo_size | 1.17718362 |
| 84 | MP0003091_abnormal_cell_migration | 1.17314729 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 1.17075488 |
| 86 | MP0001533_abnormal_skeleton_physiology | 1.16626748 |
| 87 | MP0010094_abnormal_chromosome_stability | 1.14438102 |
| 88 | MP0009053_abnormal_anal_canal | 1.12738275 |
| 89 | MP0003183_abnormal_peptide_metabolism | 1.12657072 |
| 90 | MP0002419_abnormal_innate_immunity | 1.12388134 |
| 91 | MP0004885_abnormal_endolymph | 1.11591254 |
| 92 | MP0002080_prenatal_lethality | 1.10131787 |
| 93 | MP0005266_abnormal_metabolism | 1.06388725 |
| 94 | MP0004215_abnormal_myocardial_fiber | 1.05942317 |
| 95 | MP0000767_abnormal_smooth_muscle | 1.04793244 |
| 96 | MP0003718_maternal_effect | 1.04652356 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 1.04578461 |
| 98 | MP0000858_altered_metastatic_potential | 1.02383760 |
| 99 | MP0003075_altered_response_to | 1.02257240 |
| 100 | MP0006138_congestive_heart_failure | 1.02159196 |
| 101 | MP0002998_abnormal_bone_remodeling | 1.01841117 |
| 102 | MP0005501_abnormal_skin_physiology | 1.01102462 |
| 103 | MP0001666_abnormal_nutrient_absorption | 1.00055216 |
| 104 | MP0002127_abnormal_cardiovascular_syste | 0.99129946 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.99063201 |
| 106 | MP0009931_abnormal_skin_appearance | 0.98836214 |
| 107 | MP0008569_lethality_at_weaning | 0.98509026 |
| 108 | MP0005025_abnormal_response_to | 0.98414857 |
| 109 | MP0002106_abnormal_muscle_physiology | 0.98262884 |
| 110 | MP0004036_abnormal_muscle_relaxation | 0.96182872 |
| 111 | MP0001545_abnormal_hematopoietic_system | 0.96090191 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.96090191 |
| 113 | MP0002822_catalepsy | 0.95710829 |
| 114 | MP0003890_abnormal_embryonic-extraembry | 0.95664390 |
| 115 | MP0002796_impaired_skin_barrier | 0.94434571 |
| 116 | MP0003137_abnormal_impulse_conducting | 0.92878377 |
| 117 | MP0005451_abnormal_body_composition | 0.92322914 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.91857626 |
| 119 | MP0004145_abnormal_muscle_electrophysio | 0.91648808 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.91549879 |
| 121 | MP0005187_abnormal_penis_morphology | 0.89304140 |
| 122 | MP0003690_abnormal_glial_cell | 0.88649825 |
| 123 | MP0001851_eye_inflammation | 0.88432854 |
| 124 | MP0010030_abnormal_orbit_morphology | 0.88067600 |
| 125 | MP0000733_abnormal_muscle_development | 0.87153064 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.86811614 |
| 127 | MP0008874_decreased_physiological_sensi | 0.86808233 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.86525035 |
| 129 | MP0009703_decreased_birth_body | 0.86183113 |
| 130 | MP0001544_abnormal_cardiovascular_syste | 0.85382169 |
| 131 | MP0005385_cardiovascular_system_phenoty | 0.85382169 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.84700821 |
| 133 | MP0003115_abnormal_respiratory_system | 0.84535381 |
| 134 | MP0004858_abnormal_nervous_system | 0.84370409 |
| 135 | MP0000579_abnormal_nail_morphology | 0.84339932 |
| 136 | MP0000759_abnormal_skeletal_muscle | 0.83966174 |
| 137 | MP0003123_paternal_imprinting | 0.83934036 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.83274868 |
| 139 | MP0002060_abnormal_skin_morphology | 0.82922581 |
| 140 | MP0000598_abnormal_liver_morphology | 0.82836498 |
| 141 | MP0002396_abnormal_hematopoietic_system | 0.80773626 |
| 142 | MP0002254_reproductive_system_inflammat | 0.80181091 |
| 143 | MP0008770_decreased_survivor_rate | 0.78403339 |
| 144 | MP0006036_abnormal_mitochondrial_physio | 0.78354184 |
| 145 | MP0000266_abnormal_heart_morphology | 0.78263508 |
| 146 | MP0000685_abnormal_immune_system | 0.75946969 |
| 147 | MP0005369_muscle_phenotype | 0.75612986 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.74995409 |
| 149 | MP0005390_skeleton_phenotype | 0.74771417 |
| 150 | MP0003763_abnormal_thymus_physiology | 0.74179197 |
| 151 | MP0002877_abnormal_melanocyte_morpholog | 0.73898353 |
| 152 | MP0003635_abnormal_synaptic_transmissio | 0.73250161 |
| 153 | MP0003283_abnormal_digestive_organ | 0.72987304 |
| 154 | MP0010307_abnormal_tumor_latency | 0.72741177 |
| 155 | MP0004133_heterotaxia | 0.70862244 |
| 156 | MP0000703_abnormal_thymus_morphology | 0.69795350 |
| 157 | MP0000462_abnormal_digestive_system | 0.69171205 |
| 158 | MP0004270_analgesia | 0.68317459 |
| 159 | MP0005023_abnormal_wound_healing | 0.67606325 |
| 160 | MP0002098_abnormal_vibrissa_morphology | 0.67482377 |
| 161 | MP0003866_abnormal_defecation | 0.67436370 |
| 162 | MP0003634_abnormal_glial_cell | 0.66173123 |
| 163 | MP0003045_fibrosis | 0.64321878 |
| 164 | MP0002932_abnormal_joint_morphology | 0.64177520 |
| 165 | MP0004808_abnormal_hematopoietic_stem | 0.63989219 |
| 166 | MP0000470_abnormal_stomach_morphology | 0.61511081 |
| 167 | MP0003948_abnormal_gas_homeostasis | 0.61510758 |
| 168 | MP0002933_joint_inflammation | 0.61000931 |
| 169 | MP0002108_abnormal_muscle_morphology | 0.60479332 |
| 170 | MP0009384_cardiac_valve_regurgitation | 0.60000533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.71247956 |
| 2 | Hyperglycinemia (HP:0002154) | 4.69003414 |
| 3 | Hyperglycinuria (HP:0003108) | 4.44324866 |
| 4 | Ependymoma (HP:0002888) | 3.80917198 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 3.79584577 |
| 6 | Hypochromic microcytic anemia (HP:0004840) | 3.77683988 |
| 7 | Abnormality of glycine metabolism (HP:0010895) | 3.74613673 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.74613673 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.70170522 |
| 10 | Gout (HP:0001997) | 3.56616919 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.49629043 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 3.47553358 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.26856193 |
| 14 | Broad face (HP:0000283) | 3.24277374 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.22368615 |
| 16 | Atrioventricular block (HP:0001678) | 2.98093809 |
| 17 | Xanthomatosis (HP:0000991) | 2.97234800 |
| 18 | Hyperammonemia (HP:0001987) | 2.94800169 |
| 19 | Astrocytoma (HP:0009592) | 2.89056533 |
| 20 | Abnormality of the astrocytes (HP:0100707) | 2.89056533 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 2.88752003 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.80237949 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 2.76748045 |
| 24 | Abnormality of the fingertips (HP:0001211) | 2.73867896 |
| 25 | Increased IgE level (HP:0003212) | 2.64440849 |
| 26 | Muscle fiber splitting (HP:0003555) | 2.63684780 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63090178 |
| 28 | Difficulty climbing stairs (HP:0003551) | 2.60993364 |
| 29 | Abnormality of the labia minora (HP:0012880) | 2.58494247 |
| 30 | Hyperglycemia (HP:0003074) | 2.57806072 |
| 31 | Bundle branch block (HP:0011710) | 2.57168507 |
| 32 | Hyperacusis (HP:0010780) | 2.54514056 |
| 33 | Hypolipoproteinemia (HP:0010981) | 2.52199976 |
| 34 | Shallow orbits (HP:0000586) | 2.49908033 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 2.49245088 |
| 36 | Exercise-induced myalgia (HP:0003738) | 2.47562080 |
| 37 | Ketosis (HP:0001946) | 2.46274943 |
| 38 | Impulsivity (HP:0100710) | 2.43955792 |
| 39 | Abnormality of the Achilles tendon (HP:0005109) | 2.43648457 |
| 40 | Ventricular fibrillation (HP:0001663) | 2.43585669 |
| 41 | Increased connective tissue (HP:0009025) | 2.43353318 |
| 42 | Thin bony cortex (HP:0002753) | 2.42917968 |
| 43 | Metaphyseal cupping (HP:0003021) | 2.42726681 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.42149948 |
| 45 | Cervical subluxation (HP:0003308) | 2.41798191 |
| 46 | Multiple enchondromatosis (HP:0005701) | 2.40342149 |
| 47 | Polycythemia (HP:0001901) | 2.39798140 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.39173669 |
| 49 | Spastic diplegia (HP:0001264) | 2.38969957 |
| 50 | Glioma (HP:0009733) | 2.35532411 |
| 51 | Pseudobulbar signs (HP:0002200) | 2.34630200 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.31712434 |
| 53 | Protrusio acetabuli (HP:0003179) | 2.30815119 |
| 54 | Sudden death (HP:0001699) | 2.30075998 |
| 55 | Disproportionate tall stature (HP:0001519) | 2.25924596 |
| 56 | Ankle clonus (HP:0011448) | 2.25084587 |
| 57 | Shawl scrotum (HP:0000049) | 2.24345549 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.23247562 |
| 59 | Global brain atrophy (HP:0002283) | 2.23201741 |
| 60 | Long palpebral fissure (HP:0000637) | 2.22389995 |
| 61 | Dysmetric saccades (HP:0000641) | 2.21824914 |
| 62 | Difficulty running (HP:0009046) | 2.21554401 |
| 63 | Reticulocytosis (HP:0001923) | 2.21207010 |
| 64 | Tetraplegia (HP:0002445) | 2.20706734 |
| 65 | Complement deficiency (HP:0004431) | 2.18279388 |
| 66 | J-shaped sella turcica (HP:0002680) | 2.17317401 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.17082082 |
| 68 | Achilles tendon contracture (HP:0001771) | 2.14742931 |
| 69 | Aneurysm (HP:0002617) | 2.14479602 |
| 70 | Heart block (HP:0012722) | 2.13201474 |
| 71 | Hyporeflexia of lower limbs (HP:0002600) | 2.12630486 |
| 72 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11859742 |
| 73 | Gingivitis (HP:0000230) | 2.10913220 |
| 74 | Stridor (HP:0010307) | 2.10894683 |
| 75 | EMG: neuropathic changes (HP:0003445) | 2.10347262 |
| 76 | Hypoglycemic coma (HP:0001325) | 2.10137418 |
| 77 | Mitral regurgitation (HP:0001653) | 2.08819931 |
| 78 | Hypercortisolism (HP:0001578) | 2.08668540 |
| 79 | Annular pancreas (HP:0001734) | 2.08279333 |
| 80 | Distal lower limb amyotrophy (HP:0008944) | 2.07898859 |
| 81 | Ventricular tachycardia (HP:0004756) | 2.07395673 |
| 82 | Cellulitis (HP:0100658) | 2.06862631 |
| 83 | Ulnar bowing (HP:0003031) | 2.04994130 |
| 84 | Peritonitis (HP:0002586) | 2.04639376 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.01729755 |
| 86 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00850891 |
| 87 | Bronchomalacia (HP:0002780) | 1.99847787 |
| 88 | Myopathic facies (HP:0002058) | 1.99437082 |
| 89 | Flat acetabular roof (HP:0003180) | 1.99123455 |
| 90 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98797376 |
| 91 | Germ cell neoplasia (HP:0100728) | 1.98689139 |
| 92 | Exercise-induced muscle cramps (HP:0003710) | 1.98481573 |
| 93 | Easy fatigability (HP:0003388) | 1.97308443 |
| 94 | Skin nodule (HP:0200036) | 1.97304584 |
| 95 | Epidermoid cyst (HP:0200040) | 1.97302305 |
| 96 | Turricephaly (HP:0000262) | 1.97000638 |
| 97 | Abnormal atrioventricular conduction (HP:0005150) | 1.96239309 |
| 98 | Myoglobinuria (HP:0002913) | 1.95958442 |
| 99 | Cholelithiasis (HP:0001081) | 1.95615155 |
| 100 | Increased purine levels (HP:0004368) | 1.94526439 |
| 101 | Hyperuricemia (HP:0002149) | 1.94526439 |
| 102 | Broad metatarsal (HP:0001783) | 1.93785082 |
| 103 | Abnormality of the salivary glands (HP:0010286) | 1.91382731 |
| 104 | Neoplasm of the oral cavity (HP:0100649) | 1.91130854 |
| 105 | Areflexia of lower limbs (HP:0002522) | 1.89566573 |
| 106 | Lymphangioma (HP:0100764) | 1.88753213 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87128017 |
| 108 | Biconcave vertebral bodies (HP:0004586) | 1.87090102 |
| 109 | Abnormality of macrophages (HP:0004311) | 1.87084947 |
| 110 | Distal upper limb amyotrophy (HP:0007149) | 1.85513095 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.85513095 |
| 112 | Cortical dysplasia (HP:0002539) | 1.84857149 |
| 113 | Neuronal loss in central nervous system (HP:0002529) | 1.84586049 |
| 114 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.84576928 |
| 115 | Angiofibromas (HP:0010615) | 1.84565540 |
| 116 | Adenoma sebaceum (HP:0009720) | 1.84565540 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.82949892 |
| 118 | Ventricular arrhythmia (HP:0004308) | 1.82857259 |
| 119 | Ketoacidosis (HP:0001993) | 1.82054439 |
| 120 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.81695447 |
| 121 | Status epilepticus (HP:0002133) | 1.81539172 |
| 122 | Slow saccadic eye movements (HP:0000514) | 1.81100439 |
| 123 | Neoplasm of striated muscle (HP:0009728) | 1.80476063 |
| 124 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75845862 |
| 125 | Polygenic inheritance (HP:0010982) | 1.75817694 |
| 126 | Irritability (HP:0000737) | 1.75730968 |
| 127 | Spinal canal stenosis (HP:0003416) | 1.75092936 |
| 128 | Facial hemangioma (HP:0000329) | 1.74976863 |
| 129 | Rhabdomyolysis (HP:0003201) | 1.74541232 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.74313203 |
| 131 | Dislocated radial head (HP:0003083) | 1.74094169 |
| 132 | Recurrent abscess formation (HP:0002722) | 1.73703678 |
| 133 | Abnormality of the radial head (HP:0003995) | 1.73451800 |
| 134 | Hypochromic anemia (HP:0001931) | 1.73372143 |
| 135 | Rib fusion (HP:0000902) | 1.72134654 |
| 136 | Abnormality of nucleobase metabolism (HP:0010932) | 1.71365124 |
| 137 | Myositis (HP:0100614) | 1.70939974 |
| 138 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70782261 |
| 139 | Genu recurvatum (HP:0002816) | 1.70536673 |
| 140 | Poikilocytosis (HP:0004447) | 1.68737111 |
| 141 | Precocious puberty (HP:0000826) | 1.68713525 |
| 142 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.68467503 |
| 143 | Abnormality of lateral ventricle (HP:0030047) | 1.67188476 |
| 144 | Cerebral inclusion bodies (HP:0100314) | 1.67051694 |
| 145 | Onion bulb formation (HP:0003383) | 1.67031632 |
| 146 | Abnormal gallbladder morphology (HP:0012437) | 1.66820353 |
| 147 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.66635397 |
| 148 | Neoplasm of the heart (HP:0100544) | 1.66480513 |
| 149 | Abnormality of purine metabolism (HP:0004352) | 1.66199963 |
| 150 | Blue sclerae (HP:0000592) | 1.66199397 |
| 151 | Thin ribs (HP:0000883) | 1.65410776 |
| 152 | Asymmetry of the thorax (HP:0001555) | 1.65403513 |
| 153 | Hand muscle atrophy (HP:0009130) | 1.64293381 |
| 154 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.64019289 |
| 155 | Lower limb amyotrophy (HP:0007210) | 1.63404337 |
| 156 | Abnormality of the thoracic spine (HP:0100711) | 1.62786406 |
| 157 | Visceral angiomatosis (HP:0100761) | 1.62636794 |
| 158 | Pointed chin (HP:0000307) | 1.62583087 |
| 159 | Esophageal varix (HP:0002040) | 1.62467973 |
| 160 | Abnormality of methionine metabolism (HP:0010901) | 1.61974408 |
| 161 | Medulloblastoma (HP:0002885) | 1.61865359 |
| 162 | Fragile skin (HP:0001030) | 1.61608202 |
| 163 | Abnormality of the aortic arch (HP:0012303) | 1.61464649 |
| 164 | Abnormal vertebral ossification (HP:0100569) | 1.61436273 |
| 165 | Deformed sella turcica (HP:0002681) | 1.61263751 |
| 166 | Atelectasis (HP:0100750) | 1.61043571 |
| 167 | Asymmetric septal hypertrophy (HP:0001670) | 1.60812775 |
| 168 | Prolonged partial thromboplastin time (HP:0003645) | 1.60725402 |
| 169 | Gastrointestinal infarctions (HP:0005244) | 1.59953946 |
| 170 | Pelvic girdle muscle weakness (HP:0003749) | 1.59485128 |
| 171 | Dilatation of the ascending aorta (HP:0005111) | 1.59336278 |
| 172 | Neonatal onset (HP:0003623) | 1.59208998 |
| 173 | Sleep apnea (HP:0010535) | 1.59106381 |
| 174 | Recurrent bacterial skin infections (HP:0005406) | 1.58941531 |
| 175 | Macroorchidism (HP:0000053) | 1.58733965 |
| 176 | Enlarged penis (HP:0000040) | 1.58173964 |
| 177 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.57926109 |
| 178 | Back pain (HP:0003418) | 1.57719632 |
| 179 | Decreased motor nerve conduction velocity (HP:0003431) | 1.55689621 |
| 180 | Abnormality of binocular vision (HP:0011514) | 1.54828681 |
| 181 | Diplopia (HP:0000651) | 1.54828681 |
| 182 | Hyperparathyroidism (HP:0000843) | 1.54827664 |
| 183 | Mitral valve prolapse (HP:0001634) | 1.54348855 |
| 184 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.54056370 |
| 185 | Mucopolysacchariduria (HP:0008155) | 1.54056370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.91839919 |
| 2 | PRPF4B | 3.40011939 |
| 3 | TRIB3 | 3.16369266 |
| 4 | NEK1 | 3.12162409 |
| 5 | LATS2 | 2.95544926 |
| 6 | SMG1 | 2.69630851 |
| 7 | BCKDK | 2.37124435 |
| 8 | EPHA2 | 2.27517246 |
| 9 | AKT3 | 2.16151280 |
| 10 | ICK | 2.15218598 |
| 11 | PKN2 | 2.08971401 |
| 12 | LATS1 | 2.02239803 |
| 13 | PNCK | 2.02006907 |
| 14 | RIPK4 | 1.97122997 |
| 15 | MAP3K9 | 1.95565810 |
| 16 | NEK2 | 1.87075857 |
| 17 | WEE1 | 1.79775183 |
| 18 | MARK2 | 1.79033430 |
| 19 | TNK2 | 1.69139295 |
| 20 | TTK | 1.68109946 |
| 21 | STK38 | 1.64833993 |
| 22 | EPHB1 | 1.64768847 |
| 23 | ALK | 1.63990547 |
| 24 | ERN1 | 1.60196005 |
| 25 | EEF2K | 1.57152843 |
| 26 | TYRO3 | 1.54507785 |
| 27 | PRKD2 | 1.52434408 |
| 28 | TTN | 1.51096283 |
| 29 | FGFR4 | 1.45872863 |
| 30 | BUB1 | 1.41989361 |
| 31 | PDK3 | 1.41679397 |
| 32 | PDK4 | 1.41679397 |
| 33 | TSSK6 | 1.37614539 |
| 34 | TAOK1 | 1.37379030 |
| 35 | * MTOR | 1.36826795 |
| 36 | BRD4 | 1.33501386 |
| 37 | PHKG2 | 1.32554067 |
| 38 | PHKG1 | 1.32554067 |
| 39 | SIK1 | 1.30723514 |
| 40 | RPS6KA2 | 1.26590259 |
| 41 | RIPK1 | 1.24831735 |
| 42 | MAP3K1 | 1.22205572 |
| 43 | MAP2K4 | 1.21798763 |
| 44 | SIK3 | 1.18479954 |
| 45 | GRK6 | 1.16735939 |
| 46 | MAP4K1 | 1.16646532 |
| 47 | MAP3K6 | 1.16160913 |
| 48 | MAP3K10 | 1.15565176 |
| 49 | STK38L | 1.15218838 |
| 50 | CDK4 | 1.13729465 |
| 51 | DYRK3 | 1.12523996 |
| 52 | PAK6 | 1.09593951 |
| 53 | PDGFRA | 1.06457454 |
| 54 | MAP3K13 | 1.05432739 |
| 55 | CAMKK1 | 1.04000566 |
| 56 | ZAP70 | 1.02702213 |
| 57 | RPS6KC1 | 1.02488603 |
| 58 | RPS6KL1 | 1.02488603 |
| 59 | IRAK4 | 1.02133480 |
| 60 | PINK1 | 0.99895795 |
| 61 | PDPK1 | 0.97866030 |
| 62 | HIPK2 | 0.95335876 |
| 63 | CDK6 | 0.94929930 |
| 64 | MARK1 | 0.94819258 |
| 65 | MAP3K7 | 0.93760469 |
| 66 | PLK1 | 0.91088891 |
| 67 | RPS6KB2 | 0.90175070 |
| 68 | BMX | 0.88638201 |
| 69 | * PRKAA1 | 0.86040449 |
| 70 | TYK2 | 0.84520617 |
| 71 | MAP3K4 | 0.81890702 |
| 72 | MAP2K2 | 0.81660742 |
| 73 | RPS6KA6 | 0.81543051 |
| 74 | RET | 0.80903339 |
| 75 | CSK | 0.79829881 |
| 76 | MAPK11 | 0.79169414 |
| 77 | IRAK2 | 0.78744509 |
| 78 | KSR2 | 0.77404204 |
| 79 | PTK6 | 0.76499310 |
| 80 | CSNK1E | 0.76472100 |
| 81 | BLK | 0.76408155 |
| 82 | CHEK2 | 0.74890025 |
| 83 | CDK2 | 0.73162416 |
| 84 | STK3 | 0.72980996 |
| 85 | IRAK3 | 0.72485448 |
| 86 | FES | 0.71923764 |
| 87 | CDK7 | 0.71874288 |
| 88 | TBK1 | 0.70348019 |
| 89 | STK11 | 0.69420184 |
| 90 | PDK1 | 0.69145257 |
| 91 | PRKCI | 0.69133329 |
| 92 | MAPKAPK3 | 0.68818362 |
| 93 | MAP2K3 | 0.66455460 |
| 94 | CHEK1 | 0.65975472 |
| 95 | CAMK1D | 0.65856684 |
| 96 | DDR2 | 0.65348948 |
| 97 | MAPK7 | 0.63839980 |
| 98 | PDK2 | 0.63498085 |
| 99 | PRKCH | 0.62468188 |
| 100 | SGK3 | 0.62341834 |
| 101 | UHMK1 | 0.61531387 |
| 102 | PAK4 | 0.61448352 |
| 103 | AKT2 | 0.61345571 |
| 104 | PTK2 | 0.61021127 |
| 105 | CAMK4 | 0.58246497 |
| 106 | CAMK1 | 0.56288268 |
| 107 | HCK | 0.55582615 |
| 108 | DYRK1B | 0.55453331 |
| 109 | RPS6KA1 | 0.54828560 |
| 110 | MAP3K11 | 0.54739101 |
| 111 | CDC42BPA | 0.53518034 |
| 112 | CAMK1G | 0.52754262 |
| 113 | MAP3K3 | 0.51648165 |
| 114 | LRRK2 | 0.51223214 |
| 115 | GSK3A | 0.50136777 |
| 116 | CSNK1D | 0.49578176 |
| 117 | FGFR3 | 0.49240494 |
| 118 | ARAF | 0.48531256 |
| 119 | PRKD1 | 0.47126047 |
| 120 | NTRK3 | 0.47116537 |
| 121 | SIK2 | 0.46343182 |
| 122 | MAP3K2 | 0.45925751 |
| 123 | SGK223 | 0.45528067 |
| 124 | SGK494 | 0.45528067 |
| 125 | FGR | 0.45506766 |
| 126 | FGFR1 | 0.45346466 |
| 127 | PIM1 | 0.45329662 |
| 128 | ERBB2 | 0.44728938 |
| 129 | AURKA | 0.44654533 |
| 130 | CHUK | 0.44520539 |
| 131 | JAK2 | 0.44518400 |
| 132 | MAPK12 | 0.44478306 |
| 133 | CDK1 | 0.43910552 |
| 134 | LMTK2 | 0.43531077 |
| 135 | MAP3K8 | 0.43469904 |
| 136 | PLK3 | 0.42958518 |
| 137 | MAPK10 | 0.42708018 |
| 138 | KSR1 | 0.42514698 |
| 139 | DYRK2 | 0.42380653 |
| 140 | PRKD3 | 0.42170635 |
| 141 | AURKB | 0.41908874 |
| 142 | PRKAA2 | 0.41741582 |
| 143 | PRKG2 | 0.41737566 |
| 144 | PRKCZ | 0.41024536 |
| 145 | NTRK1 | 0.40905338 |
| 146 | GSK3B | 0.40781913 |
| 147 | BTK | 0.40635775 |
| 148 | DAPK2 | 0.40607465 |
| 149 | RPS6KA3 | 0.40222141 |
| 150 | PDGFRB | 0.39756199 |
| 151 | MAP3K5 | 0.39254798 |
| 152 | DMPK | 0.38947093 |
| 153 | MAPK8 | 0.38372638 |
| 154 | TAOK2 | 0.38235754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.96133807 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60957171 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.23616477 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.23032578 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00661559 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.98406167 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.72355765 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54920106 |
| 9 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.19288199 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.10013586 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.06962426 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00961830 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99466203 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92886366 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91148817 |
| 16 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.87365094 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82015773 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.81030048 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.77285193 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75234079 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.74838529 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.73491856 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68258488 |
| 24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.60669767 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.59225622 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53792529 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52402326 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51460124 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51119543 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49137584 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48359219 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47203384 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45582435 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.44227115 |
| 35 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.43920075 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42047657 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.40083630 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.40071231 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40005499 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.36949346 |
| 41 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.35681091 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35009904 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32949639 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30938607 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.30391081 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.30171936 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28904336 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.28732786 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28406399 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.25584322 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23252333 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22483557 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21519393 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20824697 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18222992 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17757634 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17480689 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 1.16686684 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.11419483 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09945475 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08176917 |
| 62 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06854575 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06713070 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05979990 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 1.03083388 |
| 66 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03001092 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02924695 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99761322 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95518152 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94816511 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.94290121 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.94204297 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.94141156 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94012011 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93306666 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92985912 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.92642825 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92284932 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91217100 |
| 80 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89952643 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.89938976 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.89338698 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87708984 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87528023 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87045572 |
| 86 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86182922 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85416553 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84519541 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.84416558 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84345574 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.84003291 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83795467 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83364552 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83107155 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82916446 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82855540 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82061152 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.81988648 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81889772 |
| 100 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81120046 |
| 101 | Melanogenesis_Homo sapiens_hsa04916 | 0.80870983 |
| 102 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80300895 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79524765 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.79480108 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.79340260 |
| 106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79182661 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78117823 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78049291 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77002263 |
| 110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76963773 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75888454 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75629879 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75332236 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74619570 |
| 115 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74587080 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74402448 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73203883 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73033500 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.72756235 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72424214 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | 0.71797682 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71603398 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70140687 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69705806 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.69313483 |
| 126 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68367870 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67961988 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67267229 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67101400 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66261108 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65364062 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64767742 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62445681 |
| 134 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61896565 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61879912 |
| 136 | Malaria_Homo sapiens_hsa05144 | 0.61766024 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61568201 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60920038 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59746684 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59396279 |
| 141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58591898 |
| 142 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58300664 |
| 143 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58010380 |
| 144 | Influenza A_Homo sapiens_hsa05164 | 0.57796758 |
| 145 | Gap junction_Homo sapiens_hsa04540 | 0.55444592 |
| 146 | Apoptosis_Homo sapiens_hsa04210 | 0.55247404 |
| 147 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52990977 |
| 148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52051742 |
| 149 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.50461872 |
| 150 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49492014 |
| 151 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47342997 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.46558533 |
| 153 | Cell cycle_Homo sapiens_hsa04110 | 0.46432522 |
| 154 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46198888 |
| 155 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46133013 |
| 156 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45078518 |
| 157 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44459347 |
| 158 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43379543 |
| 159 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43049811 |
| 160 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41121771 |
| 161 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40794453 |
| 162 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40107850 |
| 163 | Adherens junction_Homo sapiens_hsa04520 | 0.38861975 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38460422 |
| 165 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38063538 |
| 166 | Bladder cancer_Homo sapiens_hsa05219 | 0.36423487 |
| 167 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35813339 |
| 168 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33243076 |
| 169 | * Regulation of autophagy_Homo sapiens_hsa04140 | 0.32397595 |
| 170 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32202862 |
| 171 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31417757 |
| 172 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28872054 |
| 173 | Histidine metabolism_Homo sapiens_hsa00340 | 0.28670210 |
| 174 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27311403 |
| 175 | Tight junction_Homo sapiens_hsa04530 | 0.27098280 |

